Isozid-H

Quick links to important sections

Isozid-H

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Isozid-H

Property Description
Active ingredients Hexetidine, Propanol
Form Solution (topical/mucosal)
Pharmacological class Antiseptic and Disinfectant
Common purpose Local microbial control
Origin Synthetic (Hexetidine), Chemical (Propanol)

What is Isozid-H and its Pharmacological Class?

Isozid-H is defined as a fixed-dose combination medicinal product, primarily categorized as a local antiseptic and disinfectant agent. The preparation is typically presented as an alcohol-based solution intended for topical application onto mucosal surfaces, such as the mouth and throat.

The classification is directly derived from the functions of its components: Hexetidine is established as a bactericidal and fungicidal antiseptic, while Propanol provides essential disinfectant properties. Hexetidine can effectively reduce plaque accumulation compared to placebo preparations, making it a choice for supporting local oral hygiene.

Composition: A Dual-Action Combination of Hexetidine and Propanol

The core active composition of Isozid-H consists of the synthetic antiseptic agent Hexetidine and the chemical solvent and disinfectant Propanol (1-Propanol). This combination is designed to deliver complementary effects through its two active agents.

Hexetidine works to inhibit the growth and survival of various fungi and bacteria locally, while the alcohol component, Propanol, provides a strong, rapid-acting germicidal effect. Propanol is a bactericidal alcohol, contributing to the product's immediate microbial action. The presence of the Propanol base is a key differentiating feature, ensuring quick action and penetration.

General Purpose: Local Microbial Control

The overarching purpose of Isozid-H is to achieve effective, local microbial control and improve hygiene on the affected mucosal surface. This focus on local microbial suppression is the fundamental benefit of the combination product.

The simultaneous action of Propanol and Hexetidine provides both a rapid surface-killing effect and a more sustained antiseptic presence. This comprehensive, dual-action approach is concentrated at the site of application, working to suppress the local microbial populations that contribute to surface irritation and minor symptoms, such as the initial discomfort experienced in the throat. This combination possesses broad-spectrum activity against common oral pathogens.

Regulatory References

  1. StatPearls - Alcohol Sanitizer

What side effects are possible with Isozid-H?

Possible Side Effects and Safety Information

Official regulatory documents classify the potential adverse effects of Hexetidine and Propanol topical solution based primarily on post-marketing surveillance, resulting in a classification of "Not known" frequency for all reported events. This means the rate of occurrence cannot be reliably estimated from the available data.


Documented Adverse Reactions by System-Organ Class

The most commonly documented adverse reactions, though of unknown frequency, are grouped according to the physiological systems affected:

  • Immune System Disorders: Serious reactions documented include hypersensitivity reactions and angioedema (swelling of the face or throat).
  • Nervous System Disorders: Reactions may involve dysgeusia (taste disturbance) and ageusia (complete loss of taste).
  • Gastrointestinal Disorders: Effects reported include nausea, vomiting, dry mouth, and dysphagia (difficulty swallowing).
  • General Disorders and Administration Site Conditions: Localized effects involve application site reactions, which can include irritation, discolouration, inflammation, and transient anaesthesia (local numbness) in the mouth and throat.

High-Level Safety Constraints

The official labeling includes specific safety limitations regarding administration and patient population:

  • Administration Restriction: The solution is strictly for oromucosal use only and must not be swallowed due to the potential for systemic effects from the Propanol component.
  • Pediatric Safety Note: Use of the preparation is not recommended for children under 6 years. Supervision by an adult is specified for children aged 6 to 12 years.
  • Hypersensitivity: The medicine is contraindicated in individuals with known sensitivity to the active substances or any of the excipients.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation on Isozid-H, an antiseptic solution containing hexetidine and propanol, describes overdose scenarios primarily related to accidental ingestion of the alcoholic formulation.

Documented Overdose Manifestations and Risks

The primary documented risk following the ingestion of a sufficient volume is the potential for clinical signs consistent with alcohol intoxication. The regulatory profile notes that manifestations beyond those observed during routine use have not been reported from the hexetidine component itself. A theoretical risk of acute alcoholic intoxication exists if a massive dose of the solution is swallowed, particularly by a small child.

Mandatory Emergency Actions

In the event of suspected overdose or accidental ingestion, regulatory authorities mandate that patients seek immediate medical attention or contact a Poison Control Center right away. Medical consultation must be sought immediately, especially when a child has swallowed the solution.

Management and Support

Officially described management involves symptomatic treatment focused on addressing the effects of alcoholic intoxication. Healthcare professionals may consider gastric lavage, ideally within two hours following ingestion, as a supportive measure.

Therapeutic Uses of Isozid-H

What Isozid-H Treats: Main Uses and Benefits

Isozid-H is commonly used to provide localized support across a range of oral and pharyngeal conditions, applied in contexts involving inflammatory or irritative processes. In these instances, the preparation serves as part of the symptomatic management for local conditions.

The medicine is relevant in clinical settings requiring supportive therapeutic benefit for surface inflammation. Common indications include gingivitis, minor oropharyngeal infections, recurrent aphthous ulcers, and conditions involving halitosis. This supportive relief helps manage symptoms that interfere with daily comfort.

“The application of local treatments may assist with easing the symptom load on daily activities like swallowing when discomfort is heightened.”

The preparation is used across therapeutic domains where short-term symptomatic assistance is needed for hygiene issues relevant in contexts involving heightened systemic burden. This may help patients cope more steadily with symptom fluctuations and may assist with maintaining functional stability in routine oral health.

Quick Fact: Symptomatic Support for Localized Discomfort
Isozid-H is relevant for managing soreness, irritation, and itchiness that appear during conditions presenting with systemic or localized discomfort, contributing to general well-being during symptomatic phases.

Regulatory References

  1. Health Products Regulatory Authority (HPRA) Summary of Product Characteristics

Eligibility and Restrictions for Use

Who Can and Cannot Use Isozid-H?

The population eligibility for Isozid-H (Hexetidine, Propanol solution) is strictly governed by regulatory documentation, focusing on contraindications and age-based restrictions.

Contraindications and Prohibited Use

Isozid-H must not be used by patients with a known hypersensitivity or allergy to the active ingredients Hexetidine, 2-propanol, or 1-propanol, or to any other component in the formulation. Furthermore, the product is prohibited from application on mucous membranes and is not suitable for treating open wounds or for use as alcohol compresses.


Age and Conditional Eligibility

Standard use is restricted to the adult population, 18 years of age and older. Use in infants, during pregnancy, and while breastfeeding is subject to a specific regulatory restriction: repeated large-area applications at short intervals must be avoided.


Eligibility Summary

Classification Rule
Allowed Population Adults (18 years and older) for skin disinfection.
Contraindicated Hypersensitivity to active ingredients.
Prohibited Site Application to mucous membranes.
Conditional Use Infants, pregnant, and breastfeeding individuals.

Eligibility rules are defined by official government documents to ensure the product is used appropriately for its labeled purpose as an alcohol-based disinfectant.

What should I know about interactions with other medicines?

The official regulatory profile for Isozid-H is primarily characterized by the absence of known systemic drug interactions, reflecting its intended use as a localized antiseptic on mucosal surfaces. Minimal systemic absorption of the active ingredients, Hexetidine and Propanol, means the product does not typically interfere with the metabolism or action of systemically administered medications (e.g., through CYP-enzyme pathways).

However, two specific interaction domains are formally documented in regulatory labeling, governing local use and accidental systemic exposure.

Local Incompatibility and Timing Rules

The Hexetidine component is a cationic agent, making it chemically incompatible with anionic agents, such as those often contained in common dentifrices (toothpastes). This interaction is not a safety concern, but it can compromise the antiseptic effectiveness of the product. Regulatory information stipulates a timing-based constraint: the mouth must be thoroughly rinsed with water between the use of any anionic oral product and the administration of this solution to prevent local inactivation.

Pharmacodynamic Interaction with Alcohol

A specific risk concerning the solution's composition is documented. Due to the presence of an alcohol base (Propanol/ethanol), there is a documented potential for a pharmacodynamic reinforcement with alcohol. In cases of massive, accidental ingestion—a scenario far beyond normal topical application—there is a formal risk of symptoms consistent with acute alcoholic intoxication. This interaction is explicitly classified in the overdose management section of official documents as the primary systemic concern.

Mechanism of Action

Enzyme-Mediated Prodrug Activation

Isozid-H (Isoniazid) functions as a prodrug, requiring activation within the mycobacterial cell by the enzyme catalase-peroxidase, KatG. This specific enzymatic interaction converts Isoniazid into reactive radical species and adducts, notably the Isonicotinoyl-NAD adduct. This step represents the initial molecular event of the drug's mechanism of action.

Inhibition of Mycolic Acid Synthesis and Cell Wall Disruption

The Isonicotinoyl-NAD adduct acts as a potent molecular mimic, engaging in competitive inhibition of the enzyme InhA (enoyl-acyl carrier protein reductase). InhA is a necessary component of the bacterial fatty acid synthase II (FAS-II) system, which is exclusively responsible for synthesizing mycolic acids. By blocking the activity of InhA, Isozid-H arrests the formation of these long-chain fatty acids. Mycolic acids are critical structural elements of the mycobacterial cell wall, and their depletion leads directly to a loss of cell wall integrity and subsequent structural instability in the microbial cell.

Dosage and Administration Information

How to Use Isozid-H: Administration Guidelines

The use of Isozid-H, an oromucosal solution, is based on a defined set of instructions. These instructions dictate the method, dosage, and duration of application, focusing on high-level usage patterns.


Administration Protocol and Frequency

Isozid-H is used for oromucosal use only, administered as a gargle or mouthwash. The solution is applied to the affected mucosal surface and is not intended for ingestion.

The standard single dose for adults involves using at least 15 ml of the solution. This volume is to be used undiluted. The frequency pattern is two to three times daily (2 to 3 times daily).

A critical procedural step in administration is that the solution must be spat out after the gargle or rinse. It is important to not swallow the solution, as its purpose is for local application.


Use Duration and Specific Populations

Use of this product is restricted to short-term symptomatic support. The solution is not suitable for persistent symptoms and should only be used as part of a limited course of application.

Regarding specific populations, the solution is not recommended for use in children under 6 years of age. For older children who may use the product, the administration procedure must be supervised by an adult to ensure the correct technique. Dosing for older adults is as for adults, requiring no specific adjustment.

Procedural Key Facts Labeled Instruction
Route/Method Oromucosal use only, as a rinse or gargle.
Dose Volume At least 15 ml undiluted.
Frequency Two to three times daily.
Duration Short-term symptomatic use only.
Disposal Must be spat out after use.

Recent Clinical Evidence

Isozid-H: Recent Clinical Evidence

Evidence for Use in Gingivitis and Plaque Accumulation

The primary research exploring Gingivitis and Plaque Accumulation focuses on the active ingredient, Hexetidine. Research has explored whether this component was evaluated in short-term Randomized Controlled Trials (RCTs) and Controlled Clinical Trials, often summarized in systematic reviews. These studies examined objective measurements of Plaque Index scores and parameters of the Gingival Index, which tracks bleeding and inflammation in adult populations. Trials evaluated Hexetidine against placebo and certain other antiseptic agents; findings across trials were mixed in terms of relative measurements. The research describes changes measured only during the study period, which were typically short-term, lasting up to around six weeks.


Evidence for Use in Minor Oropharyngeal Irritation

Research has explored the use of the medicine for conditions involving outcomes related to inflammatory or irritative states, such as soreness in the mouth and throat, as well as for recurrent aphthous ulcers. These studies applied research contexts involving fluctuating or unstable symptoms, examining patient-reported outcomes describing perceived discomfort. The findings describe patterns observed in the studies where symptom evolution was tracked during short intervals. However, because the sample sizes were modest and the studies often focused on temporary physiological imbalance, certainty remains low for these specific symptomatic indications.


Long-Term Evidence and Areas of Uncertainty

Most available research was observed in studies designed to track short-term symptom changes, with typical follow-up durations ranging from a few days up to about six weeks. Due to these limited durations, there is limited information for long-term outcomes related to either chronic oral hygiene maintenance or the prevention of recurrence. Furthermore, comparative evidence is lacking for directly comparing the dual-action Isozid-H product against single-ingredient products. The evidence quality varies across studies, and data for certain groups, such as children or individuals with specific comorbid conditions, remain insufficient.

Key Studies & References

  1. Health Products Regulatory Authority (HPRA) Summary of Product Characteristics (SPC) for Hexetidine/Propanol
  2. StatPearls: Alcohols, Antiseptic

Frequently Asked Questions (FAQ)

Common questions about Isozid-H (FAQ)

Q: Is Isozid-H the same as just taking isoniazid alone?

A: No, Isozid-H is not the same as isoniazid. According to official product definitions, Isozid-H is a combination product containing the ingredients Hexetidine and Propanol, intended for local antiseptic purposes on mucosal surfaces. Isoniazid (sometimes referred to as INH) is a chemically different medication used in the systemic treatment of tuberculosis.

Q: What is the difference between Isozid-H and other similar combination drugs?

A: Isozid-H is officially defined as a fixed-dose combination product. Its distinction lies in its specific composition of the antiseptic Hexetidine and the germicidal agent Propanol. This unique dual composition is classified in regulatory documents as a local antiseptic and disinfectant solution.

Q: Can I take Isozid-H with common pain relievers like ibuprofen or paracetamol?

A: Official drug information is characterized by the absence of known systemic drug interactions. Because the product is designed for local use with minimal systemic absorption, official documents indicate it does not typically interfere with the metabolism of common systemic medicines, such as ibuprofen or paracetamol.

Q: Are there any vitamins or supplements that interact with Isozid-H?

A: Regulatory documents indicate that there are no known systemic interactions documented for Isozid-H. Since the product is for local application only, specific interactions with common vitamins or supplements are not typically addressed in the official product profile.

Q: Are there any common but mild side effects of Isozid-H?

A: All potential adverse effects reported for Isozid-H are classified as having a 'Not known' frequency, meaning the rate of occurrence cannot be reliably estimated from available data. However, localized application site reactions are documented in official safety information. These reported reactions of unknown frequency include temporary irritation, discolouration, inflammation, and transient localized numbness (anaesthesia) in the mouth and throat.

Q: Can Isozid-H cause dizziness or affect my ability to drive?

A: Documented adverse reactions, though of unknown frequency, include nervous system effects such as taste disturbance (dysgeusia) and complete loss of taste (ageusia). However, official regulatory documents do not list dizziness as a documented side effect, nor do they typically include warnings about effects on driving ability for this non-systemic product.

Q: Is Isozid-H safe for people with kidney problems?

A: Regulatory documents define the product as having minimal systemic absorption. For this reason, official product information typically does not include specific warnings or dose adjustments related to pre-existing organ conditions like kidney problems, which are usually required for systemically absorbed medicines.

Q: What is the evidence regarding the combination therapy in Isozid-H?

A: The available research typically examines the Hexetidine component, with studies often having short-term durations. Regulatory summaries indicate that comparative evidence is lacking for directly comparing the dual-action Isozid-H product against single-ingredient products.

Q: How quickly does Isozid-H start working?

A: Official descriptions of the product’s function highlight that the Propanol component provides a strong, rapid-acting germicidal effect. This description is consistent with the product's focus on achieving prompt local microbial suppression at the application site.

Q: What is the usual duration of treatment with Isozid-H?

A: According to regulatory guidelines, this product is intended only for short-term symptomatic support. Official information specifies that the solution is not suitable for persistent symptoms and should only be used as part of a limited course of application.

Q: Can Isozid-H be taken with food, or must it be on an empty stomach?

A: Isozid-H is an oromucosal solution intended to be used as a gargle or rinse and must be spat out, not swallowed. The regulatory instructions focus on the local application procedure and do not specify a relationship between administration time and meals.

Q: Why is pyridoxine (Vitamin B6) sometimes recommended with this medicine?

A: The recommendation for using pyridoxine (Vitamin B6) is specifically associated with the systemic tuberculosis medication Isoniazid, not with Isozid-H (Hexetidine/Propanol). Official documents for Isozid-H, which is a local antiseptic, do not include this recommendation.

Q: Why do some people need to take Isozid-H for many months?

A: Official regulatory guidance dictates that this product is restricted to short-term symptomatic support only and is explicitly described as not suitable for persistent symptoms. The official label advises against prolonged use.

Q: How does the 'H' part of Isozid-H affect the treatment?

A: Official documentation does not specify a meaning for the 'H' in the name. However, the product name refers to the combination of the two active ingredients: Hexetidine and Propanol, which together provide complementary antiseptic and germicidal effects for local use.

Q: What should I do if my symptoms don't improve after starting Isozid-H?

A: The official guidance states that the product is not suitable for persistent symptoms. Since use is restricted to short-term symptomatic support, the label specifies that continued symptoms beyond the limited course indicate the need for re-evaluation.

Q: What if I take too much Isozid-H by accident?

A: In the event of massive, accidental ingestion, official documents warn of a potential risk of symptoms consistent with acute alcoholic intoxication due to the presence of the Propanol component. Official documents specify that in this circumstance, immediate emergency medical attention should be sought.

How should Isozid-H be stored and disposed of?

How to Store and Dispose of Isozid-H

Isozid-H (Hexetidine/Propanol solution) must be handled according to official regulatory requirements to maintain stability and ensure safety. Storage conditions are defined to protect the alcohol-based solution.


Storage Requirements

The product must be stored at a temperature not exceeding 25 C and must be protected from light. Keep the medicine in its original container and store it out of the sight and reach of children.

The shelf life after first opening the container is 12 months; do not use the product after the stated expiry date.


Disposal Instructions

Do not dispose of unused or expired Isozid-H in wastewater or household waste. The product must be returned to a pharmacist for appropriate disposal as pharmaceutical waste, in line with environmental protection guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Isozid-H found in:

A-Z Index: